Literature DB >> 8031468

Expression and transcriptional activity of AP-1, CRE, and URE binding proteins in B16 mouse melanoma subclones.

S E Rutberg1, I M Goldstein, Y M Yang, C W Stackpole, Z Ronai.   

Abstract

The expression and DNA binding activity of members of the activating protein-1 (AP-1) and activating transcription factor (ATF) families of transcription factors were analyzed in sham and ultraviolet (UV)-irradiated subclones of the B16 mouse melanoma cell system. The four subclones we used represent sequential stages in the development and progression of malignant melanoma and exhibit differences in growth and metastatic potential. Western blot analysis revealed differential expression of some AP-1 (c-jun, jun-B, and jun-D) and ATF (43- and 47-kDa cyclic AMP-responsive element binding protein (CREB) family members) in the different subclones; while c-jun expression was noted in the subclones with the greater malignant potential, jun-D was expressed in those with the lesser malignant potential. Furthermore, a delicate balance between the two forms of CREB was noted; the 47-kDa CREB appeared, when expressed exclusively, in subclones that exhibit a greater malignant potential. Electrophoretic mobility shift assays using AP-1, CRE, and UV-responsive element (URE) consensus sequences indicated that distinct complexes were formed with extracts from each of the four subclones. The complexes were competitively inhibited by each of the target sequences used, suggesting that "cross-talk" occurs between some AP-1 and ATF family members in this cell system. Moreover, a multimer of the URE sequence, cloned upstream of a chloramphenicol acetyltransferase reporter gene, was transcriptionally active and responsive to UV irradiation in two of the four subclones. UV-related transcriptional activation was directly correlated with the expression of a 43-kDa CREB. Together, these observations identify members of AP-1 and CREB families whose expression and activities correlate with the malignant potential of subclones that represent different stages in melanoma development and progression.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8031468     DOI: 10.1002/mc.2940100205

Source DB:  PubMed          Journal:  Mol Carcinog        ISSN: 0899-1987            Impact factor:   4.784


  8 in total

1.  Enhanced metastasis of B16 melanoma cells by unexpected elevated expression of the metastasis-associated TI-241 (LRF-1-, Jun-Fos-related) gene treated with antisense oligonucleotide.

Authors:  T Ishiguro; M Naito; K Hanaoka; H Nagawa; T Muto; T Tsuruo
Journal:  Clin Exp Metastasis       Date:  1998-02       Impact factor: 5.150

2.  Regulation of tumor growth and metastasis of human melanoma by the CREB transcription factor family.

Authors:  D Jean; M Bar-Eli
Journal:  Mol Cell Biochem       Date:  2000-09       Impact factor: 3.396

Review 3.  Transcriptional control of melanoma metastasis: the importance of the tumor microenvironment.

Authors:  Russell R Braeuer; Maya Zigler; Gabriel J Villares; Andrey S Dobroff; Menashe Bar-Eli
Journal:  Semin Cancer Biol       Date:  2010-12-13       Impact factor: 15.707

4.  Novel GHRH antagonists suppress the growth of human malignant melanoma by restoring nuclear p27 function.

Authors:  Luca Szalontay; Andrew V Schally; Petra Popovics; Irving Vidaurre; Awtar Krishan; Marta Zarandi; Ren-Zhi Cai; Anna Klukovits; Norman L Block; Ferenc G Rick
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

Review 5.  Involvement of metabotropic glutamate receptor 1, a G protein coupled receptor, in melanoma development.

Authors:  Yarí E Marín; Suzie Chen
Journal:  J Mol Med (Berl)       Date:  2004-08-21       Impact factor: 4.599

6.  Silencing cAMP-response element-binding protein (CREB) identifies CYR61 as a tumor suppressor gene in melanoma.

Authors:  Andrey S Dobroff; Hua Wang; Vladislava O Melnikova; Gabriel J Villares; Maya Zigler; Li Huang; Menashe Bar-Eli
Journal:  J Biol Chem       Date:  2009-07-24       Impact factor: 5.157

Review 7.  Understanding signaling cascades in melanoma.

Authors:  Pablo Lopez-Bergami; Boris Fitchman; Ze'ev Ronai
Journal:  Photochem Photobiol       Date:  2007-12-15       Impact factor: 3.421

8.  Inhibitory effect of ATF3 antisense oligonucleotide on ectopic growth of HT29 human colon cancer cells.

Authors:  T Ishiguro; H Nagawa; M Naito; T Tsuruo
Journal:  Jpn J Cancer Res       Date:  2000-08
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.